MedTrace Logo

Prognostic Understanding in ESC (ProgESC Study)

NCT06067087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2025-01-03

No results posted yet for this study

Summary

This study aims to assess how aware patients with advanced cancer are about their prognosis when they are referred to an Enhanced Supportive Care (ESC) service. Further, the study aim to assess the relationship between patients prognostic understanding and their mental health, quality of life, trust in medical professionals as well as their perception of the care they receive.

The study will involve adult patients with advanced cancer who are referred to the ESC service at London University College Hospital. Patients who agree to participate will provide consent and answer a questionnaire. The questionnaire will cover their prognostic awareness, psychological symptoms, and quality of life. It takes about 20 minutes to complete and can be done online via RedCap

Conditions

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Patrick Stone, Prof · University College, London

  • Joanna Sheppard, MD · University College London Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06067087 on ClinicalTrials.gov